Germany could be the next country to switch erectile dysfunction treatment sildenafil from prescription-only to OTC status.
At its next meeting on 25 January 2022, the country’s Expert Committee for Prescription will consider whether to remove sildenafil (50mg, oral use) and preparations of xylometazoline and ipratropium bromide...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?